Extended and saturation needle biopsy for the diagnosis of prostate cancer
Abstract The diagnosis of prostate cancer hinges on the use of systematic ultrasound-guided transrectal needle biopsy. The choice of technique is important, especially for patients with a history of a negative biopsy. Saturation biopsy can be considered for patients at risk of cancer who are willing...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Chrouser, Kristin L. [verfasserIn] Lieber, Michael M. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2004 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
Enthalten in: Current prostate reports - Philadelphia, Pa. : Current Science, 2003, 2(2004), 4 vom: 01. Dez., Seite 155-159 |
|---|---|
| Übergeordnetes Werk: |
volume:2 ; year:2004 ; number:4 ; day:01 ; month:12 ; pages:155-159 |
| Links: |
|---|
| DOI / URN: |
10.1007/s11918-004-0016-7 |
|---|
| Katalog-ID: |
SPR023014598 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR023014598 | ||
| 003 | DE-627 | ||
| 005 | 20230520013016.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201006s2004 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11918-004-0016-7 |2 doi | |
| 035 | |a (DE-627)SPR023014598 | ||
| 035 | |a (SPR)s11918-004-0016-7-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 100 | 1 | |a Chrouser, Kristin L. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Extended and saturation needle biopsy for the diagnosis of prostate cancer |
| 264 | 1 | |c 2004 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract The diagnosis of prostate cancer hinges on the use of systematic ultrasound-guided transrectal needle biopsy. The choice of technique is important, especially for patients with a history of a negative biopsy. Saturation biopsy can be considered for patients at risk of cancer who are willing to accept the side effects and who understand that clinically insignificant cancers can be detected. For patients with previous negative sextant biopsies, expanding the zones sampled and increasing the number of biopsy cores can help detect significant cancers while they are still confined. However, as extended biopsy becomes more commonly performed for initial diagnosis, there likely will be less need for saturation biopsy protocols. | ||
| 650 | 4 | |a Prostate Cancer |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Prostate Biopsy |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Peripheral Zone |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Sextant Biopsy |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Prostate Needle Biopsy |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Lieber, Michael M. |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current prostate reports |d Philadelphia, Pa. : Current Science, 2003 |g 2(2004), 4 vom: 01. Dez., Seite 155-159 |w (DE-627)51163806X |w (DE-600)2233535-3 |x 1544-225X |7 nnns |
| 773 | 1 | 8 | |g volume:2 |g year:2004 |g number:4 |g day:01 |g month:12 |g pages:155-159 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s11918-004-0016-7 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a GBV_ILN_702 | ||
| 912 | |a GBV_ILN_2190 | ||
| 951 | |a AR | ||
| 952 | |d 2 |j 2004 |e 4 |b 01 |c 12 |h 155-159 | ||
| author_variant |
k l c kl klc m m l mm mml |
|---|---|
| matchkey_str |
article:1544225X:2004----::xeddnstrtonelbosfrhdanss |
| hierarchy_sort_str |
2004 |
| publishDate |
2004 |
| allfields |
10.1007/s11918-004-0016-7 doi (DE-627)SPR023014598 (SPR)s11918-004-0016-7-e DE-627 ger DE-627 rakwb eng 610 ASE Chrouser, Kristin L. verfasserin aut Extended and saturation needle biopsy for the diagnosis of prostate cancer 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract The diagnosis of prostate cancer hinges on the use of systematic ultrasound-guided transrectal needle biopsy. The choice of technique is important, especially for patients with a history of a negative biopsy. Saturation biopsy can be considered for patients at risk of cancer who are willing to accept the side effects and who understand that clinically insignificant cancers can be detected. For patients with previous negative sextant biopsies, expanding the zones sampled and increasing the number of biopsy cores can help detect significant cancers while they are still confined. However, as extended biopsy becomes more commonly performed for initial diagnosis, there likely will be less need for saturation biopsy protocols. Prostate Cancer (dpeaa)DE-He213 Prostate Biopsy (dpeaa)DE-He213 Peripheral Zone (dpeaa)DE-He213 Sextant Biopsy (dpeaa)DE-He213 Prostate Needle Biopsy (dpeaa)DE-He213 Lieber, Michael M. verfasserin aut Enthalten in Current prostate reports Philadelphia, Pa. : Current Science, 2003 2(2004), 4 vom: 01. Dez., Seite 155-159 (DE-627)51163806X (DE-600)2233535-3 1544-225X nnns volume:2 year:2004 number:4 day:01 month:12 pages:155-159 https://dx.doi.org/10.1007/s11918-004-0016-7 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_40 GBV_ILN_702 GBV_ILN_2190 AR 2 2004 4 01 12 155-159 |
| spelling |
10.1007/s11918-004-0016-7 doi (DE-627)SPR023014598 (SPR)s11918-004-0016-7-e DE-627 ger DE-627 rakwb eng 610 ASE Chrouser, Kristin L. verfasserin aut Extended and saturation needle biopsy for the diagnosis of prostate cancer 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract The diagnosis of prostate cancer hinges on the use of systematic ultrasound-guided transrectal needle biopsy. The choice of technique is important, especially for patients with a history of a negative biopsy. Saturation biopsy can be considered for patients at risk of cancer who are willing to accept the side effects and who understand that clinically insignificant cancers can be detected. For patients with previous negative sextant biopsies, expanding the zones sampled and increasing the number of biopsy cores can help detect significant cancers while they are still confined. However, as extended biopsy becomes more commonly performed for initial diagnosis, there likely will be less need for saturation biopsy protocols. Prostate Cancer (dpeaa)DE-He213 Prostate Biopsy (dpeaa)DE-He213 Peripheral Zone (dpeaa)DE-He213 Sextant Biopsy (dpeaa)DE-He213 Prostate Needle Biopsy (dpeaa)DE-He213 Lieber, Michael M. verfasserin aut Enthalten in Current prostate reports Philadelphia, Pa. : Current Science, 2003 2(2004), 4 vom: 01. Dez., Seite 155-159 (DE-627)51163806X (DE-600)2233535-3 1544-225X nnns volume:2 year:2004 number:4 day:01 month:12 pages:155-159 https://dx.doi.org/10.1007/s11918-004-0016-7 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_40 GBV_ILN_702 GBV_ILN_2190 AR 2 2004 4 01 12 155-159 |
| allfields_unstemmed |
10.1007/s11918-004-0016-7 doi (DE-627)SPR023014598 (SPR)s11918-004-0016-7-e DE-627 ger DE-627 rakwb eng 610 ASE Chrouser, Kristin L. verfasserin aut Extended and saturation needle biopsy for the diagnosis of prostate cancer 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract The diagnosis of prostate cancer hinges on the use of systematic ultrasound-guided transrectal needle biopsy. The choice of technique is important, especially for patients with a history of a negative biopsy. Saturation biopsy can be considered for patients at risk of cancer who are willing to accept the side effects and who understand that clinically insignificant cancers can be detected. For patients with previous negative sextant biopsies, expanding the zones sampled and increasing the number of biopsy cores can help detect significant cancers while they are still confined. However, as extended biopsy becomes more commonly performed for initial diagnosis, there likely will be less need for saturation biopsy protocols. Prostate Cancer (dpeaa)DE-He213 Prostate Biopsy (dpeaa)DE-He213 Peripheral Zone (dpeaa)DE-He213 Sextant Biopsy (dpeaa)DE-He213 Prostate Needle Biopsy (dpeaa)DE-He213 Lieber, Michael M. verfasserin aut Enthalten in Current prostate reports Philadelphia, Pa. : Current Science, 2003 2(2004), 4 vom: 01. Dez., Seite 155-159 (DE-627)51163806X (DE-600)2233535-3 1544-225X nnns volume:2 year:2004 number:4 day:01 month:12 pages:155-159 https://dx.doi.org/10.1007/s11918-004-0016-7 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_40 GBV_ILN_702 GBV_ILN_2190 AR 2 2004 4 01 12 155-159 |
| allfieldsGer |
10.1007/s11918-004-0016-7 doi (DE-627)SPR023014598 (SPR)s11918-004-0016-7-e DE-627 ger DE-627 rakwb eng 610 ASE Chrouser, Kristin L. verfasserin aut Extended and saturation needle biopsy for the diagnosis of prostate cancer 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract The diagnosis of prostate cancer hinges on the use of systematic ultrasound-guided transrectal needle biopsy. The choice of technique is important, especially for patients with a history of a negative biopsy. Saturation biopsy can be considered for patients at risk of cancer who are willing to accept the side effects and who understand that clinically insignificant cancers can be detected. For patients with previous negative sextant biopsies, expanding the zones sampled and increasing the number of biopsy cores can help detect significant cancers while they are still confined. However, as extended biopsy becomes more commonly performed for initial diagnosis, there likely will be less need for saturation biopsy protocols. Prostate Cancer (dpeaa)DE-He213 Prostate Biopsy (dpeaa)DE-He213 Peripheral Zone (dpeaa)DE-He213 Sextant Biopsy (dpeaa)DE-He213 Prostate Needle Biopsy (dpeaa)DE-He213 Lieber, Michael M. verfasserin aut Enthalten in Current prostate reports Philadelphia, Pa. : Current Science, 2003 2(2004), 4 vom: 01. Dez., Seite 155-159 (DE-627)51163806X (DE-600)2233535-3 1544-225X nnns volume:2 year:2004 number:4 day:01 month:12 pages:155-159 https://dx.doi.org/10.1007/s11918-004-0016-7 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_40 GBV_ILN_702 GBV_ILN_2190 AR 2 2004 4 01 12 155-159 |
| allfieldsSound |
10.1007/s11918-004-0016-7 doi (DE-627)SPR023014598 (SPR)s11918-004-0016-7-e DE-627 ger DE-627 rakwb eng 610 ASE Chrouser, Kristin L. verfasserin aut Extended and saturation needle biopsy for the diagnosis of prostate cancer 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract The diagnosis of prostate cancer hinges on the use of systematic ultrasound-guided transrectal needle biopsy. The choice of technique is important, especially for patients with a history of a negative biopsy. Saturation biopsy can be considered for patients at risk of cancer who are willing to accept the side effects and who understand that clinically insignificant cancers can be detected. For patients with previous negative sextant biopsies, expanding the zones sampled and increasing the number of biopsy cores can help detect significant cancers while they are still confined. However, as extended biopsy becomes more commonly performed for initial diagnosis, there likely will be less need for saturation biopsy protocols. Prostate Cancer (dpeaa)DE-He213 Prostate Biopsy (dpeaa)DE-He213 Peripheral Zone (dpeaa)DE-He213 Sextant Biopsy (dpeaa)DE-He213 Prostate Needle Biopsy (dpeaa)DE-He213 Lieber, Michael M. verfasserin aut Enthalten in Current prostate reports Philadelphia, Pa. : Current Science, 2003 2(2004), 4 vom: 01. Dez., Seite 155-159 (DE-627)51163806X (DE-600)2233535-3 1544-225X nnns volume:2 year:2004 number:4 day:01 month:12 pages:155-159 https://dx.doi.org/10.1007/s11918-004-0016-7 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_40 GBV_ILN_702 GBV_ILN_2190 AR 2 2004 4 01 12 155-159 |
| language |
English |
| source |
Enthalten in Current prostate reports 2(2004), 4 vom: 01. Dez., Seite 155-159 volume:2 year:2004 number:4 day:01 month:12 pages:155-159 |
| sourceStr |
Enthalten in Current prostate reports 2(2004), 4 vom: 01. Dez., Seite 155-159 volume:2 year:2004 number:4 day:01 month:12 pages:155-159 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Prostate Cancer Prostate Biopsy Peripheral Zone Sextant Biopsy Prostate Needle Biopsy |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Current prostate reports |
| authorswithroles_txt_mv |
Chrouser, Kristin L. @@aut@@ Lieber, Michael M. @@aut@@ |
| publishDateDaySort_date |
2004-12-01T00:00:00Z |
| hierarchy_top_id |
51163806X |
| dewey-sort |
3610 |
| id |
SPR023014598 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR023014598</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230520013016.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201006s2004 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s11918-004-0016-7</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR023014598</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s11918-004-0016-7-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">ASE</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Chrouser, Kristin L.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Extended and saturation needle biopsy for the diagnosis of prostate cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2004</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract The diagnosis of prostate cancer hinges on the use of systematic ultrasound-guided transrectal needle biopsy. The choice of technique is important, especially for patients with a history of a negative biopsy. Saturation biopsy can be considered for patients at risk of cancer who are willing to accept the side effects and who understand that clinically insignificant cancers can be detected. For patients with previous negative sextant biopsies, expanding the zones sampled and increasing the number of biopsy cores can help detect significant cancers while they are still confined. However, as extended biopsy becomes more commonly performed for initial diagnosis, there likely will be less need for saturation biopsy protocols.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Prostate Cancer</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Prostate Biopsy</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Peripheral Zone</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Sextant Biopsy</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Prostate Needle Biopsy</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lieber, Michael M.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Current prostate reports</subfield><subfield code="d">Philadelphia, Pa. : Current Science, 2003</subfield><subfield code="g">2(2004), 4 vom: 01. Dez., Seite 155-159</subfield><subfield code="w">(DE-627)51163806X</subfield><subfield code="w">(DE-600)2233535-3</subfield><subfield code="x">1544-225X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:2</subfield><subfield code="g">year:2004</subfield><subfield code="g">number:4</subfield><subfield code="g">day:01</subfield><subfield code="g">month:12</subfield><subfield code="g">pages:155-159</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s11918-004-0016-7</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_702</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2190</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">2</subfield><subfield code="j">2004</subfield><subfield code="e">4</subfield><subfield code="b">01</subfield><subfield code="c">12</subfield><subfield code="h">155-159</subfield></datafield></record></collection>
|
| author |
Chrouser, Kristin L. |
| spellingShingle |
Chrouser, Kristin L. ddc 610 misc Prostate Cancer misc Prostate Biopsy misc Peripheral Zone misc Sextant Biopsy misc Prostate Needle Biopsy Extended and saturation needle biopsy for the diagnosis of prostate cancer |
| authorStr |
Chrouser, Kristin L. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)51163806X |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut aut |
| collection |
springer |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
1544-225X |
| topic_title |
610 ASE Extended and saturation needle biopsy for the diagnosis of prostate cancer Prostate Cancer (dpeaa)DE-He213 Prostate Biopsy (dpeaa)DE-He213 Peripheral Zone (dpeaa)DE-He213 Sextant Biopsy (dpeaa)DE-He213 Prostate Needle Biopsy (dpeaa)DE-He213 |
| topic |
ddc 610 misc Prostate Cancer misc Prostate Biopsy misc Peripheral Zone misc Sextant Biopsy misc Prostate Needle Biopsy |
| topic_unstemmed |
ddc 610 misc Prostate Cancer misc Prostate Biopsy misc Peripheral Zone misc Sextant Biopsy misc Prostate Needle Biopsy |
| topic_browse |
ddc 610 misc Prostate Cancer misc Prostate Biopsy misc Peripheral Zone misc Sextant Biopsy misc Prostate Needle Biopsy |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Current prostate reports |
| hierarchy_parent_id |
51163806X |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Current prostate reports |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)51163806X (DE-600)2233535-3 |
| title |
Extended and saturation needle biopsy for the diagnosis of prostate cancer |
| ctrlnum |
(DE-627)SPR023014598 (SPR)s11918-004-0016-7-e |
| title_full |
Extended and saturation needle biopsy for the diagnosis of prostate cancer |
| author_sort |
Chrouser, Kristin L. |
| journal |
Current prostate reports |
| journalStr |
Current prostate reports |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2004 |
| contenttype_str_mv |
txt |
| container_start_page |
155 |
| author_browse |
Chrouser, Kristin L. Lieber, Michael M. |
| container_volume |
2 |
| class |
610 ASE |
| format_se |
Elektronische Aufsätze |
| author-letter |
Chrouser, Kristin L. |
| doi_str_mv |
10.1007/s11918-004-0016-7 |
| dewey-full |
610 |
| author2-role |
verfasserin |
| title_sort |
extended and saturation needle biopsy for the diagnosis of prostate cancer |
| title_auth |
Extended and saturation needle biopsy for the diagnosis of prostate cancer |
| abstract |
Abstract The diagnosis of prostate cancer hinges on the use of systematic ultrasound-guided transrectal needle biopsy. The choice of technique is important, especially for patients with a history of a negative biopsy. Saturation biopsy can be considered for patients at risk of cancer who are willing to accept the side effects and who understand that clinically insignificant cancers can be detected. For patients with previous negative sextant biopsies, expanding the zones sampled and increasing the number of biopsy cores can help detect significant cancers while they are still confined. However, as extended biopsy becomes more commonly performed for initial diagnosis, there likely will be less need for saturation biopsy protocols. |
| abstractGer |
Abstract The diagnosis of prostate cancer hinges on the use of systematic ultrasound-guided transrectal needle biopsy. The choice of technique is important, especially for patients with a history of a negative biopsy. Saturation biopsy can be considered for patients at risk of cancer who are willing to accept the side effects and who understand that clinically insignificant cancers can be detected. For patients with previous negative sextant biopsies, expanding the zones sampled and increasing the number of biopsy cores can help detect significant cancers while they are still confined. However, as extended biopsy becomes more commonly performed for initial diagnosis, there likely will be less need for saturation biopsy protocols. |
| abstract_unstemmed |
Abstract The diagnosis of prostate cancer hinges on the use of systematic ultrasound-guided transrectal needle biopsy. The choice of technique is important, especially for patients with a history of a negative biopsy. Saturation biopsy can be considered for patients at risk of cancer who are willing to accept the side effects and who understand that clinically insignificant cancers can be detected. For patients with previous negative sextant biopsies, expanding the zones sampled and increasing the number of biopsy cores can help detect significant cancers while they are still confined. However, as extended biopsy becomes more commonly performed for initial diagnosis, there likely will be less need for saturation biopsy protocols. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_40 GBV_ILN_702 GBV_ILN_2190 |
| container_issue |
4 |
| title_short |
Extended and saturation needle biopsy for the diagnosis of prostate cancer |
| url |
https://dx.doi.org/10.1007/s11918-004-0016-7 |
| remote_bool |
true |
| author2 |
Lieber, Michael M. |
| author2Str |
Lieber, Michael M. |
| ppnlink |
51163806X |
| mediatype_str_mv |
c |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| doi_str |
10.1007/s11918-004-0016-7 |
| up_date |
2024-07-03T16:18:20.070Z |
| _version_ |
1803575361607303168 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR023014598</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230520013016.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201006s2004 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s11918-004-0016-7</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR023014598</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s11918-004-0016-7-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">ASE</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Chrouser, Kristin L.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Extended and saturation needle biopsy for the diagnosis of prostate cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2004</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract The diagnosis of prostate cancer hinges on the use of systematic ultrasound-guided transrectal needle biopsy. The choice of technique is important, especially for patients with a history of a negative biopsy. Saturation biopsy can be considered for patients at risk of cancer who are willing to accept the side effects and who understand that clinically insignificant cancers can be detected. For patients with previous negative sextant biopsies, expanding the zones sampled and increasing the number of biopsy cores can help detect significant cancers while they are still confined. However, as extended biopsy becomes more commonly performed for initial diagnosis, there likely will be less need for saturation biopsy protocols.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Prostate Cancer</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Prostate Biopsy</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Peripheral Zone</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Sextant Biopsy</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Prostate Needle Biopsy</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lieber, Michael M.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Current prostate reports</subfield><subfield code="d">Philadelphia, Pa. : Current Science, 2003</subfield><subfield code="g">2(2004), 4 vom: 01. Dez., Seite 155-159</subfield><subfield code="w">(DE-627)51163806X</subfield><subfield code="w">(DE-600)2233535-3</subfield><subfield code="x">1544-225X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:2</subfield><subfield code="g">year:2004</subfield><subfield code="g">number:4</subfield><subfield code="g">day:01</subfield><subfield code="g">month:12</subfield><subfield code="g">pages:155-159</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s11918-004-0016-7</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_702</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2190</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">2</subfield><subfield code="j">2004</subfield><subfield code="e">4</subfield><subfield code="b">01</subfield><subfield code="c">12</subfield><subfield code="h">155-159</subfield></datafield></record></collection>
|
| score |
7.400613 |